Research
Siponimod
Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive Multiple Sclerosis patients
Cognitive Rehabilitation Research
NUI Galway are looking for people to take part in a new programme
New Research Programme
Queens researchers in £2 million bid to reverse the damage of Multiple Sclerosis
NEW! MS Research eZine
MS Research is a brand new bi-annual research eZine. In each edition we will be sharing the latest updates from scientific and social MS research, from here in Ireland and internationally.